Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$0.77 +0.03 (+4.26%)
At close: Oct 22, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Current Debt (2021)

Updated

Creative Medical Technology Holdings (CELZ) posted Current Debt of $50,000 for FY2019.

Analysis

Creative Medical Technology Holdings (CELZ) Current Debt (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -4.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 64.00 Mn
10 Creative Medical Technology Holdings 1.06 Mn -25.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -5.15 Mn
Sep 30, 2021 506,498.00
API Access

Creative Medical Technology Holdings Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=CELZ&period=max&api_key=YOUR_API_KEY